SCM

Sio Capital Management Portfolio holdings

AUM $249M
This Quarter Return
+2.51%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$326M
AUM Growth
+$326M
Cap. Flow
+$5.37M
Cap. Flow %
1.65%
Top 10 Hldgs %
44.11%
Holding
92
New
17
Increased
21
Reduced
15
Closed
17

Top Buys

1
LJPC
La Jolla Pharmaceutical Company
LJPC
$12.1M
2
WCG
Wellcare Health Plans, Inc.
WCG
$11.7M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.7M
4
NVS icon
Novartis
NVS
$8.3M
5
ELV icon
Elevance Health
ELV
$8.28M

Top Sells

1
BIIB icon
Biogen
BIIB
$18.6M
2
GILD icon
Gilead Sciences
GILD
$16M
3
CVS icon
CVS Health
CVS
$13.8M
4
ASND icon
Ascendis Pharma
ASND
$10.6M
5
NVO icon
Novo Nordisk
NVO
$8.47M

Sector Composition

1 Healthcare 87.7%
2 Technology 1.63%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FRTX
51
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.13M 0.27%
1,329,657
-286,230
-18% -$243K
INGN icon
52
Inogen
INGN
$216M
$1.01M 0.24%
15,189
– –
ACHV icon
53
Achieve Life Sciences
ACHV
$152M
$1.01M 0.24%
524,413
+102,934
+24% +$199K
IMMU
54
DELISTED
Immunomedics Inc
IMMU
$971K 0.23%
+70,000
New +$971K
UBX
55
DELISTED
Unity Biotechnology
UBX
$956K 0.23%
+100,635
New +$956K
SVRA icon
56
Savara
SVRA
$567M
$948K 0.23%
+400,000
New +$948K
AFMD
57
DELISTED
Affimed
AFMD
$769K 0.19%
267,942
– –
AXSM icon
58
Axsome Therapeutics
AXSM
$6.05B
$523K 0.13%
20,310
-22,100
-52% -$569K
OCUL icon
59
Ocular Therapeutix
OCUL
$2.12B
$263K 0.06%
+59,668
New +$263K
ACAD icon
60
Acadia Pharmaceuticals
ACAD
$4.38B
– –
0
– –
ACHC icon
61
Acadia Healthcare
ACHC
$2.12B
– –
0
– –
ASND icon
62
Ascendis Pharma
ASND
$11.8B
– –
-90,325
Closed -$10.6M
BIIB icon
63
Biogen
BIIB
$19.4B
– –
-78,596
Closed -$18.6M
BPMC
64
DELISTED
Blueprint Medicines
BPMC
– –
-3,000
Closed -$240K
GILD icon
65
Gilead Sciences
GILD
$140B
– –
-245,968
Closed -$16M
CBIO
66
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
– –
0
– –
GNFT
67
Genfit
GNFT
$200M
– –
-92,637
Closed -$2.22M
IDXX icon
68
Idexx Laboratories
IDXX
$51.8B
– –
0
– –
ISRG icon
69
Intuitive Surgical
ISRG
$170B
– –
0
– –
LXRX icon
70
Lexicon Pharmaceuticals
LXRX
$400M
– –
0
– –
MASI icon
71
Masimo
MASI
$7.59B
– –
0
– –
MCK icon
72
McKesson
MCK
$85.4B
– –
-51,300
Closed -$6.01M
MRK icon
73
Merck
MRK
$210B
– –
0
– –
NVO icon
74
Novo Nordisk
NVO
$251B
– –
-162,000
Closed -$8.47M
PEN icon
75
Penumbra
PEN
$10.6B
– –
0
– –
1 2
3
4